Form EFFECT Enveric Biosciences,
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | April 29, 2026 5:00 P.M. |
| Form: | S-3 | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Manhattan Legal Separation Attorney Ryan Besinque Explains New York Separation Agreements and Judgments of Separation
- NVIDIA and KAIST Launch Joint AI Research Lab to Accelerate AI Innovation in Korea
- ARBOR Launches COMX-C710 AI Module Powered by AMD Ryzen™ AI Embedded X100 Processors for Robotics and Physical AI Applications
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
